FIELD: medicine, dermatology.
SUBSTANCE: invention relates to a method for treatment of fungus-like mycosis. Method involves administration of ridostinum as an inductor of endogenous interferon as intramuscular injections in the dose 8 mg, 2 times per a week, 6 injections for a course. Prednisolon is prescribed simultaneously with ridostinum in the dose 0.5 mg/kg/day for 21 days followed by reducing the dose by 2.5 mg for 3 days. Treatment results to attainment of high clinical effectiveness in patients at the II-d and III-d stage of process and reduces complication risk.
EFFECT: improved method for treatment.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENTS WITH MYCOSIS FUNGOIDES | 2010 |
|
RU2455982C1 |
| DIFFERENTIAL DIAGNOSIS METHOD FOR DIAGNOSING ERYTHRODERMIC MALIGNANT T-CELL SKIN LYMPHOMA AND OTHER ERYTHRODERMATITIS CASES | 2004 |
|
RU2286570C2 |
| METHOD FOR TREATING THE CASES OF MALIGNANT SKIN LYMPHOMA | 1999 |
|
RU2182481C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF FUNGOUS MYCOSIS FROM CHRONIC DERMATOSES | 2018 |
|
RU2687274C1 |
| ACANTHOLYTIC PEMPHIGUS TREATMENT METHOD | 2009 |
|
RU2391984C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR SKIN DISEASES | 2010 |
|
RU2466398C2 |
| METHOD OF TREATING PEMPHIGUS VULGARIS | 2012 |
|
RU2530625C2 |
| METHOD OF CURE FOR ERYTHRODERMA PSORIATICUM | 2008 |
|
RU2369394C1 |
| METHOD FOR DETERMINATION OF MYCOSIS FUNGOIDES STAGE | 2017 |
|
RU2639448C1 |
| METHOD FOR DEFINITION OF THE STAGE OF MYCOSIS FUNGOIDEA | 2017 |
|
RU2660542C1 |
